Verjee Rehan
SEC insider (Form 3/4/5 filer). CIK 0001880637. Director at Tyra Biosciences, Inc. (TYRA). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in CARLSBAD, CA.
Companies Verjee Rehan has filed insider reports for
- Tyra Biosciences, Inc. (TYRA): Director
Verjee Rehan
CIK: 0001880637
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TYRA
Tyra Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 9, 2026TYRA
Tyra Biosciences, Inc.
PurchaseDirect972 shares at avg. $20.58$20K - May 28, 2026TYRA
Tyra Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
13.2K shares- - May 29, 2025TYRA
Tyra Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
22.2K shares-
1-3 of 3 transactions